Milad Alucozai Overview

  • Investor Type
  • Angel

  • Status
  • Active

  • Investments
  • 38

  • Portfolio
  • 28

  • Exits
  • 8

Exits

Milad Alucozai General Information

Description

Dr. Milad Alucozai serves as General Partner at Pamir Ventures. He most recently served as Head of Biotechnology and Deep Technology at BoxOne Ventures. He is a Co-Founder & serves as Board Member at Revalia Bio. He previously served as Venture Partner at Entrepreneur First, Advisor at Old Silver VC and Lifeomic, Entrepreneur-in-Residence supporting ARPA-H grants, and on the founding team of Corstem. Dr. Alucozai is a scientist, startup founder, and investor with more than two decades of experience in deep technology, life sciences, biotechnology, healthcare, and technology commercialization. His experience includes working with companies from founding through IPO or M&A, including Numerate and Absci, as well as serving as an External Advisor to AstraZeneca, a Board Observer at Talus Bioscience and CytoTronics, an Advisor at Mykonos, a Visiting Scholar in Healthcare Engineering at the Regenstrief Center, and a mentor through the Creative Destruction Lab and Harvard University iLabs. Dr. Alucozai previously served on the board of Mekonos and as a Board Observer at CytoTronics. Dr. Alucozai holds a BS in Neuroscience from Purdue University's Honors Program, a Master's in Immunology from National University of Ireland, and a PhD from Indiana University. He served as Board Member at Seqera.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Corporate Office
  • San Francisco, CA
  • United States

Milad Alucozai Investments (38)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Coding Bio 05-Sep-2023 Seed Round Drug Discovery Generating Revenue
Future Fields 22-Feb-2023 Biotechnology Generating Revenue
Phycobloom 20-Jan-2023 Other Energy Generating Revenue
GEn1E Lifesciences 21-Dec-2022 Biotechnology Clinical Trials - Phase 2
Lobby Studio 28-Oct-2022 Business/Productivity Software Out of Business
Arpeggio 01-Aug-2022 Drug Discovery Out of Business
Endpoint Health 13-Jun-2022 Drug Discovery Pre-Clinical Trials
CytoTronics 28-Apr-2022 Discovery Tools (Healthcare) Generating Revenue
OMx Personal Health Analytics 11-Apr-2022 Later Stage VC Discovery Tools (Healthcare) Generating Revenue
Oath Care 09-Feb-2022 Early Stage VC Other Healthcare Services Out of Business

Milad Alucozai Exits (8)

Company Name Exit Date Exit Type Exit Size
Arpeggio 22-Jul-2026 Out of Business
CytoTronics 22-Jan-2026
Lobby Studio 19-Dec-2024
Oath Care 13-May-2024
Notable Labs 16-Oct-2023
Juno Diagnostics 31-Jul-2023
Volumetric (Biotechnology) 01-Dec-2021 Merger/Acquisition
Mekonos Out of Business

Milad Alucozai Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Milad Alucozai Co-Investors (110)

Name With Exits Lead Partner Series Industry
BoxOne Ventures 5 Series chart Industry bar
Builders VC Series chart Industry bar
Khosla Ventures Series chart Industry bar
Matthew De Silva Series chart Industry bar
The Venture Collective Series chart Industry bar

Milad Alucozai FAQs

  • Who is Milad Alucozai?

    Milad Alucozai is an angel Investor who has made 38 investments.

  • What kind of investor is Milad Alucozai?

    Milad Alucozai is an angel investor.

  • What does Milad Alucozai do?

    As an angel investor, Milad Alucozai invests personal money into promising companies, typically in exchange for equity.

  • What has Milad Alucozai invested in?

    Milad Alucozai has made numerous investments in companies like Coding Bio, Future Fields, and Phycobloom within the Drug Discovery, Biotechnology, and Energy industries.

  • What has Milad Alucozai invested in recently?

    Milad Alucozai's latest investment was on 05-Sep-2023 in Coding Bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process